The global cannabis market is expected to grow to $630 billion by 2040, compared to $12 billion today. The cannabis industry is expected to expand into a $22 billion hemp-derived CBD product market in 2022, up from $591 million in 2018. Looking ahead, Canada’s cannabis industry is projected to grow six-fold in market value by 2026, up from $1.6 billion in 2018.
Cannabis is considered a drug and is illegal on the federal level in the US, but some states have legalized the recreational use of cannabis. In recent history, the classified drug has been gaining more acceptance in the general public as it may have many therapeutic and healing benefits.
Cannabis ETFs invest in companies that:
- Grow, distribute or sell cannabis.
- Research the medical uses of cannabis, such as those in the pharmaceutical and biotech industries.
- Have significant exposure to cannabis stocks, such as those in the alcohol and tobacco industries.
Click on the tabs below to see more information on Cannabis ETFs, including historical performance, dividends, holdings, expense ratios, technical indicators, analysts reports and more. Click on an ETF ticker or name to go to its detail page, for in-depth news, financial data and graphs. By default the list is ordered by descending total market capitalization.
As of 10/01/20